NCT02867956 2026-03-10Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian CancerSun Yat-sen UniversityPhase 2 Completed35 enrolled
NCT07033819 2026-02-27Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With ApatinibCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Recruiting48 enrolled